Clinical Trial & Research Opportunities
Clinical trials are research studies that test new medical, surgical or behavioral interventions in people to determine if they are safe and effective. They are a key part of clinical research and are considered the safest and fastest way to find new and improved treatment options. Clinical trials and research studies are essential for understanding lupus and the development of new therapies. Whether to participate in a clinical trial is a personal decision that should be made willingly and without pressure. You should only participate if you feel comfortable and informed about the process.
Below is a list of current clinical trial and research opportunities (surveys, focus groups, interviews) and additional resources in the state of Michigan and beyond. Participants are often compensated.
Cullinan Therapeutics T Cell Engager Clinical Trial for SLE
T cell engagers are a new type of immunotherapy designed to redirect the body’s own immune system to target harmful cells. T cell engagers may offer a less intensive, more accessible alternative to CAR-T therapy while still providing meaningful disease control. A T cell engager temporarily brings a patient’s existing T cells into contact with B cells by binding them together and so the T cell can destroy the B cell.
Researchers are studying CLN-978 in a Phase 1 clinical trial for people with moderate to severe lupus who have not responded adequately to at least two previous treatment options. Learn more about participating in the Cullinan Therapeutics clinical trial by visiting: https://cullinantherapeutics.com/clinical-trials
University of Michigan Health Research
The University of Michigan has ongoing research opportunities for those with lupus. Click here to learn more.
Additional Resources: Lupus and Allied Diseases Association, Inc.
The Lupus and Allied Diseases Association, Inc. (LADA) is an all-volunteer national patient advocacy organization dedicated to enhancing quality of life by enlightening and empowering individuals impacted by lupus and allied diseases and other conditions of unmet need to become proactive in their medical care.
LADA has compiled a thorough list of clinical trial participation resources. View the list here.